496 related articles for article (PubMed ID: 30258447)
1. Esculetin Ameliorates Psoriasis-Like Skin Disease in Mice by Inducing CD4
Chen Y; Zhang Q; Liu H; Lu C; Liang CL; Qiu F; Han L; Dai Z
Front Immunol; 2018; 9():2092. PubMed ID: 30258447
[TBL] [Abstract][Full Text] [Related]
2. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
[TBL] [Abstract][Full Text] [Related]
3. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice.
Gao J; Chen F; Fang H; Mi J; Qi Q; Yang M
Biol Res; 2020 Oct; 53(1):48. PubMed ID: 33081840
[TBL] [Abstract][Full Text] [Related]
4. PSORI-CM02 Formula Increases CD4+ Foxp3+ Regulatory T Cell Frequency and Ameliorates Imiquimod-Induced Psoriasis in Mice.
Chen H; Liu H; Lu C; Wang M; Li X; Zhao H; Yan Y; Yu W; Han L; Dai Z
Front Immunol; 2017; 8():1767. PubMed ID: 29358932
[TBL] [Abstract][Full Text] [Related]
5. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8
Chen Y; Yan Y; Liu H; Qiu F; Liang CL; Zhang Q; Huang RY; Han L; Lu C; Dai Z
Theranostics; 2020; 10(23):10466-10482. PubMed ID: 32929360
[TBL] [Abstract][Full Text] [Related]
7. Betulinic acid suppresses Th17 response and ameliorates psoriasis-like murine skin inflammation.
Liu C; Chen Y; Lu C; Chen H; Deng J; Yan Y; Xu YY; Liu H; Huang H; Wei J; Han L; Dai Z
Int Immunopharmacol; 2019 Aug; 73():343-352. PubMed ID: 31129421
[TBL] [Abstract][Full Text] [Related]
8. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
9. Esculetin from Fraxinus rhynchophylla attenuates atopic skin inflammation by inhibiting the expression of inflammatory cytokines.
Jeong NH; Yang EJ; Jin M; Lee JY; Choi YA; Park PH; Lee SR; Kim SU; Shin TY; Kwon TK; Jang YH; Song KS; Kim SH
Int Immunopharmacol; 2018 Jun; 59():209-216. PubMed ID: 29656211
[TBL] [Abstract][Full Text] [Related]
10.
Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX
Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689
[TBL] [Abstract][Full Text] [Related]
11. Lck signaling inhibition causes improvement in clinical features of psoriatic inflammation through reduction in inflammatory cytokines in CD4+ T cells in imiquimod mouse model.
Al-Harbi NO; Ahmad SF; Almutairi M; Alanazi AZ; Ibrahim KE; Alqarni SA; Alqahtani F; Alhazzani K; Alharbi M; Alasmari F; Nadeem A
Cell Immunol; 2022 Jun; 376():104531. PubMed ID: 35576719
[TBL] [Abstract][Full Text] [Related]
12. TLR2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation through Decrease in Regulatory T Cells and Impaired IL-10 Production.
Nakao M; Sugaya M; Fujita H; Miyagaki T; Morimura S; Shibata S; Asano Y; Sato S
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202847
[TBL] [Abstract][Full Text] [Related]
13. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic anti-psoriatic effects of myeloid-derived suppressor cells in combination with systemic tacrolimus (FK-506) in an imiquimod-induced mouse model of psoriasis.
Park MY; Choo YK; Jeon SH; Jang WG; Lee JH; Park JH; Kim CH
Int Immunopharmacol; 2020 Sep; 86():106553. PubMed ID: 32563057
[TBL] [Abstract][Full Text] [Related]
15. Kaempferol modulates IFN-γ induced JAK-STAT signaling pathway and ameliorates imiquimod-induced psoriasis-like skin lesions.
Li Y; Cui H; Li S; Li X; Guo H; Nandakumar KS; Li Z
Int Immunopharmacol; 2023 Jan; 114():109585. PubMed ID: 36527884
[TBL] [Abstract][Full Text] [Related]
16. Anti-psoriatic effect of myeloid-derived suppressor cells on imiquimod-induced skin inflammation in mice.
Kim CH; Yoo JK; Jeon SH; Lim CY; Lee JH; Koo DB; Park MY
Scand J Immunol; 2019 Mar; 89(3):e12742. PubMed ID: 30548969
[TBL] [Abstract][Full Text] [Related]
17. Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-α/IFN-γ-induced inflammatory response in keratinocytes and T cell-derived IL-17.
Lin ZM; Ma M; Li H; Qi Q; Liu YT; Yan YX; Shen YF; Yang XQ; Zhu FH; He SJ; Tang W; Zuo JP
Pharmacol Res; 2018 Mar; 129():443-452. PubMed ID: 29155016
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory Effect of Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice by Histamine H4 Receptor Agonist 4-Methylhistamine.
Kim CH; Lee JM; Yoo JK; Kim JS; Kim SU; Chang KT; Choo YK
Scand J Immunol; 2016 Jun; 83(6):409-17. PubMed ID: 26900758
[TBL] [Abstract][Full Text] [Related]
19. Topical Application of Tetrandrine Nanoemulsion Promotes the Expansion of CD4
Chen S; Lin Z; He T; Islam MS; Xi L; Liao P; Yang Y; Zheng Y; Chen X
Front Immunol; 2022; 13():800283. PubMed ID: 35464441
[TBL] [Abstract][Full Text] [Related]
20. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]